Two new asterosaponins, lethasteriosides A (1) and B (2), were isolated along with previously known thornasteroside A (3), anasteroside A (4), and luidiaquinoside (5) from the ethanolic extract of the Far Eastern starfish Lethasterias fusca. The structures of the new compounds were elucidated by extensive NMR and ESIMS techniques, and chemical transformations. Compounds 1 and 3-5 did not show any apparent cytotoxicity against cancer cell lines T-47D, RPMI-7951, and HCT-116, but glycoside 1, at concentration of 20 M, demonstrated considerable inhibition of the T-47D (97%), RPMI-7951 (90%) and НСТ-116 (90%) cell colony formations in a soft agar clonogenic assay.
The secondary metabolites from starfish (phylum Echinodermata, class Asteroidea) are characterized by a wide diversity of polar steroids, including polyhydroxylated steroids and steroid glycosides. Besides rare glycosides with cyclic carbohydrate chains, starfish contain two main structural groups of steroid glycosides, namely asterosaponins and glycosylated polyhydroxysteroids [1] [2] [3] . Asterosaponins are steroid oligoglycosides containing 3-O-sulfated  9(11) -3,6-dihydroxysteroid aglycons and carbohydrate chains with usually five or six sugars attached to C-6. These glycosides have been reported to have different biological activities, such as cytotoxic, hemolytic, antiviral, antibacterial, antifungal, and antibiofouling effects. It is considered that asterosaponins protect starfish against predatory fish [1] [2] [3] . Recently, we have isolated and structurally elucidated three new and three known glycosides of polyhydroxysteroids, two known polyhydroxysteroids, and one sulfated aglycon of asterosaponins from the ethanolic extract of the Far Eastern starfish Lethasterias fusca (order Forcipulatida, family Asteriidae), collected at Posyet Bay in the Sea of Japan [4] . Here, we report the results of studies on the oligoglycoside fraction from the same species.
The water-soluble materials from the EtOH extract of L. fusca were sequentially subjected to chromatographic separation on columns of Polychrom 1, Sephadex LH-20, Si gel and Florisil, followed by HPLC on semi-preparative and analytical Diasfer-110-C18 columns to yield two new asterosaponins, lethasteriosides A (1) and B (2), along with previously known glycosides 3-5 (Figure 1 ). Compounds 3-5 were identified by comparison of their 1 H and 13 C NMR, and MS spectra with those of thornasteroside A (3), which was first reported from the starfish Acanthaster planci [3, 5] , anasteroside A (4) from Anasterias minuta [6] , and luidiaquinoside (5) from Luidia quinaria [7] . Structures of the new compounds were mainly elucidated by 1 Table 2) . Along with mass spectral information, these data revealed the presence of five monosaccharide residues in the oligosaccharide moiety of 1. The coupling constants (7.5-7.8 Hz) of the anomeric proton atoms were indicative of a -configuration of all glycosidic bonds. The presence of three 6-deoxy-sugar units was supported by three methyl doublets at  H 1.57, 1.46, and 1.83 ppm. The irradiation of anomeric protons in the 1D TOCSY experiments gave the chemical shifts and coupling constants of the H-1 -H-5 proton signals of quinovose and xylose residues, and H-1 -H-4 of galactose and fucose residues; irradiation of protons of the deoxygroup of fucose gave the signal of H-5 of fucose. 1 H-1 H COSY, HSQC, HMBC, and NOESY experiments led to the assignment of all proton and carbon signals of the carbohydrate chain of 1 ( Table  2 ). The spectral data of monosaccharides of the oligosaccharide moiety strictly coincided with those of terminal -D-fucopyranosyl and -D-quinovopyranosyl residues, and internal 3-О-substituted -D-quinovopyranosyl, 2,4-di-О-substituted -D-xylopyranosyl, and 2-О-substituted -D-galactopyranosyl residues in the reported spectra of the known thornasteroside A (3) [3, 5] . with TFA was carried out to ascertain its monosaccharide composition. Alcoholysis of the mixture of sugars by (R)-(−)-octanol followed by acetylation, GC analysis, and comparison with corresponding derivatives of standard monosaccharides according to the procedure of Leontein et al. [10] allowed us to establish the D-configuration for all the monosaccharide units comprising the carbohydrate moiety of 1 (xylose, quinovose, galactose and fucose). The attachment of the oligosaccharide chain to the steroid aglycon and the position of interglycosidic linkages were deduced from long-range correlations in the NOESY and HMBC spectra ( Table 2) [9] , and NOESY correlations of H 3 -18/H-20 and H 3 -21/H-12. The (23R)-configuration was suggested by analogy with nipoglycoside D on the basis of coincidence of the corresponding signals in the NMR spectra [11] . Hence, (20R,23R)-3,6,23-trihydroxy-5-cholest-9(11)-en-3-yl sulfate as the steroid aglycon was proposed for glycoside 2.
Elucidation of the pentasaccharide moiety of 2 was carried out in the same manner as for compound 1 ( Table 2 ). The reference of proton resonances of monosaccharides with the close chemical shifts of anomeric atoms (Qui I and Fuc, and Xyl and Qui II) was made using a 2D selective TOCSY-DQFCOSY experiment [12] . The (+)and (−)-ESI-MS/MS spectra of glycoside 2 showed fragmentary peaks, obtained due to losses of a sulfate group, consecutive losses of five sugar units (three deoxyhexoses, hexose and pentose), as well as peaks of fragments of the oligosaccharide chain and a peak for a sulfate group at m/z 97 [HSO 4 ] -(see Experimental). On the basic of the above-mentioned data, it was established that glycoside 2 has the same carbohydrate chain as 1. , 23-trihydroxy-5-cholest-9(11)-en-3-yl sulfate. Compound 2 has an aglycon with the rare 23-hydroxy-cholestane side chain previously reported only from the starfish Distolasterias nipon [11] and Asterias rubens [13] .
The in vitro cytotoxicity of glycosides 1 and 3-5 against human breast T-47D, colorectal carcinoma HCT-116, and melanoma a The average of at least two independent assays that were performed in triplicate. Compound concentrations ranging from 10 to 160 M were tested for each cell line. Further, we examined the effect of glycoside 1 (20 M on the proliferation of these cells (Figure 2 ). The number of HCT-116 and RPMI-7951 cells in culture was decreased after 72 h by 34 and 36%, respectively. At the same time, 1 did not show significant inhibition of the proliferation of T-47D cells.
To evaluate the effect of 1 on the colony formation of cancer cells, we conducted a soft agar clonogenic assay with the T-47D, HCT-116 and RPMI-7951 cancer cell lines. The cells were treated with compound 1 at 5, 10, and 20 M in the soft agar matrix and incubated at 37C in a 5% CO 2 incubator for 4 weeks. The results indicated that 1 reduced the number of colonies of T-47D, НСТ-116, and RPMI-7951 cells in a dose dependent manner. This glycoside at a concentration 10 M inhibited colony formation by 81% (T-47D), 53% (HCT-116), and 65% (RPMI-7951), and 1, at a concentration of 20 M, reduced the number of colonies by 97% (T-47D), 90% (HCT-116), and 90% (RPMI-7951), in comparison with non-treated cells (control, 0% of inhibition) ( Fig. 3 ). It is interesting to note that compound 1 was nontoxic against human breast cancer cell line T-47D, but completely inhibited the colony formation of this cell line. Based on these observations, lethasterioside A (1) seems to be promising for further investigation as an anticancer and cancer preventive agent.
Experimental
General: Optical rotations were determined on a Perkin-Elmer 141 polarimeter. The 1 H and 13 C NMR spectra were recorded on a Bruker DRX 500 spectrometer at 500.13 and 125.76 MHz, respectively, and a Bruker AVANCE III 700 spectrometer at 700.13 and 176.04 MHz, respectively, using tetramethylsilane as the internal standard. The NMR spectra of compound 2 were obtained in a Shigemi ampoule in CD 3 OD. The HR ESI mass spectra were recorded on an Agilent 6510 Q-TOF LC/MS mass spectrometer; the samples were dissolved in MeOH (c 0.001 mg/mL). GC analysis was conducted on an Agilent 6580 Series apparatus, with the carrier gas He (1.7 mL/min) at 100ºC (0.5 min) to 250ºC (5ºC/min, 10 min) and a capillary column HP-5 MS (30 m × 0.25 mm). The temperatures of the injector and the detector were 150 and 280ºC, respectively.
HPLC separations were carried out on an Agilent 1100 Series chromatograph equipped with a differential refractometer. Diasfer-110-C18 (10 m, 250  15 mm) and Diasfer-110-C18 (5 m, 250  4.6 mm) columns were used. Low pressure column liquid chromatography was performed using Polychrom 1 (powdered Teflon, Biolar, Latvia), Sephadex LH-20 (Sigma, Chemical Co), Si gel KSK (50160 m, Sorbpolimer, Krasnodar, Russia) and Florisil (200  300 mesh, Aldrich Chemical Co.). Sorbfil Si gel plates (4.5  6.0 cm, 517 m, Sorbpolimer, Krasnodar, Russia) were used for thin-layer chromatography. 
